Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among a group of largely HIV-positive gay and bi men, Zepatier (grazoprevir/elbasvir) boasted a 99 percent cure rate.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
The Center for HIV Law and Policy, the Harm Reduction Coalition and the National Viral Hepatitis Roundtable are behind the effort.
Research found that healthcare providers could do better at preventing drug interactions.
The ambitious plan will allocate an initial $5 million to help ramp up treatment, remove barriers to care and increase harm reduction.
Researchers advocate prescribing DAAs during the early phases of hep C infection for those coinfected with HIV.
Curing hepatitis C is a priority for people also living with HIV.
The group focuses on treatment, research, policy and education around HIV and hepatitis C.
Diagnosed with hepatitis C and HIV, Gloria Searson became a powerful advocate for many.
60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
Robert R. Redfield, MD, is a longtime HIV researcher. But he’s also controversial.
The Centers for Disease Control and Protection (CDC) recommends hepatitis B and C testing for everyone with HIV.
The Human Rights Campaign aims to expose the vice president’s alarming viewpoints, such as that condoms are “too modern” to fight STDs.
Researchers surveyed adults admitted to the emergency department at a hospital in the Bronx.
Advocacy organizations are “alarmed” by the findings.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.